Analysts await Tobira Therapeutics, Inc. (NASDAQ:TBRA) to report earnings on May, 09 for the fiscal quarter ending Mar 2016.

They expect $-0.53 EPS, down 100% or $0.53 from last year’s $n/a per share.

The biggest institutional shareholders in Tobira Therapeutics, Inc. include One Palmer Square Associates V, L.L.C. which owns 4 million shares in the company valued at $4.63 million. Frazier Healthcare V, LP is the second biggest holder with 3 million shares currently valued at 3.15 million whilst Novo A/S has 2 million shares valued at 24.84 million.

Total shares held by institutions as of the most recent company filings are 17,103,909 with a reported 1,087,128 bought and 366,357 sold. These holdings make up 51.81% of the company’s outstanding shares.

Currently insiders hold 3,243,364 shares in the business which makes up 17.24% of shares. The biggest holder currently is Robert A. Kierlin who owns 3,214,955 shares (17.09% of those outstanding), whilst Christopher Paul Rusconi holds 22,904 (0.12% of shares outstanding) and Christopher Courts holds 5,405 (0.03% of shares outstanding).

The stock decreased 2.65% or $0.22 during the last trading session.